7th India-Japan medical product regulatory symposium held at New Delhi
Enhanced collaboration under the Memorandum of Cooperation (MoC) between India and Japan in medical product regulations
Enhanced collaboration under the Memorandum of Cooperation (MoC) between India and Japan in medical product regulations
The initiative aims to empower individuals to take proactive steps towards monitoring their health
Partners with Yifan Pharmaceutical to launch Synovian injection for osteoarthritis in China
Renews GMP certifications for India and Malaysia sites
Higher efficacy was observed in mRNA-1283 compared to Spikevax in adults 18 years of age and older
The Indian pharmaceutical industry is projected to reach US$ 130 billion by 2030
Dr. Reddy’s gets exclusive commercialization rights in the United States (U.S.) as well as semi-exclusive rights in Europe and United Kingdom (UK)
The acquisition is immediately accretive and creates a compelling, single-stop, multi-continent partner for biopharma companies
EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%
Subscribe To Our Newsletter & Stay Updated